Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Age-related immune differences in influenza and herpes zoster vaccination
2020-005682-13Phase 4Completed
- Sponsor
- Radboudumc
- Start
- Jan 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Zoster vaccine recombinant in influenza and herpes zoster (HZ) (2 arms), sponsored by Radboudumc. Primary endpoint: Functional assessment of vaccine response. Started Jan 2021; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
influenzaherpes zoster (HZ)
Beyond the preview
Go deeper on 2020-005682-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005682-13.